50 results on '"Escargueil, Alexandre E"'
Search Results
2. The Multidrug Transporter, P-Glycoprotein, Actively Mediates Cholesterol Redistribution in the Cell Membrane
3. Supplementary Figure 4 from Trabectedin and Its C Subunit Modified Analogue PM01183 Attenuate Nucleotide Excision Repair and Show Activity toward Platinum-Resistant Cells
4. Supplementary Figure 2 from Trabectedin and Its C Subunit Modified Analogue PM01183 Attenuate Nucleotide Excision Repair and Show Activity toward Platinum-Resistant Cells
5. Supplementary Figure 1 from Trabectedin and Its C Subunit Modified Analogue PM01183 Attenuate Nucleotide Excision Repair and Show Activity toward Platinum-Resistant Cells
6. Supplementary Figure 3 from Trabectedin and Its C Subunit Modified Analogue PM01183 Attenuate Nucleotide Excision Repair and Show Activity toward Platinum-Resistant Cells
7. Supplementary Figure 3 from Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status
8. Legend to supplementary data from Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status
9. Supplementary Figure 1 from Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status
10. Supplementary Figure 2 from Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status
11. Unexpected talaroenamine derivatives and an undescribed polyester from the fungus Talaromyces stipitatus ATCC10500
12. The C-Terminal Acidic Tail Modulates the Anticancer Properties of HMGB1
13. The DNA damage response to monofunctional anticancer DNA binders
14. Replication and Homologous Recombination Repair Regulate DNA Double-Strand Break Formation by the Antitumor Alkylator Ecteinascidin 743
15. Saccharomyces cerevisiae as a model system to study the response to anticancer agents
16. Colorectal Cancer and Immunity: From the Wet Lab to Individuals
17. PARPs and the DNA damage response
18. Secondary Metabolites from the Culture of the Marine-derived Fungus Paradendryphiella salina PC 362H and Evaluation of the Anticancer Activity of Its Metabolite Hyalodendrin
19. The NER proteins XPC and CSB, but not ERCC1, regulate the sensitivity to the novel DNA binder S23906: Implications for recognition and repair of antitumor alkylators
20. DNA repair pathways involved in repair of lesions induced by 5-fluorouracil and its active metabolite FdUMP
21. Catalytic topoisomerase II inhibitors in cancer therapy
22. Dipyridamole as a new drug to prevent Epstein-Barr virus reactivation
23. Perspective: plasticity, the enemy of the good
24. Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status
25. Influence of liposomal irinotecan (nal-IRI) and non-liposomal irinotecan, alone and in combination, on tumor growth and angiogenesis in colorectal cancer (CRC) models.
26. Antimicrobial Oligophenalenone Dimers from the Soil Fungus Talaromyces stipitatus
27. Dual inhibition of ATR and ATM potentiates the activity of trabectedin and lurbinectedin by perturbing the DNA damage response and homologous recombination repair
28. BRCA2 is needed for both repair and cell cycle arrest in mammalian cells exposed to S23906, an anticancer monofunctional DNA binder
29. Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by nintedanib, a small molecule angiokinase inhibitor
30. DNA alkylation damage and autophagy induction
31. Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status
32. EGFR- and VEGF(R)-Targeted Small Molecules Show Synergistic Activity in Colorectal Cancer Models Refractory to Combinations of Monoclonal Antibodies
33. Trabectedin and Its C Subunit Modified Analogue PM01183 Attenuate Nucleotide Excision Repair and Show Activity toward Platinum-Resistant Cells
34. Ataxia telangiectasia mutated- and Rad3-related kinase drives both the early and the late DNA-damage response to the monofunctional antitumour alkylator S23906
35. Abstract A240: Synergistic effects of a small molecule EGFR/HER2 inhibitor in combination with a triple angiokinase inhibitor in colorectal cancer xenografts refractory to combinations of cetuximab and bevacizumab
36. Abstract A125: Profound impact of the nucleotide excision repair proteins XPC and CSB, but not ERCC1, on the resistance to an antitumor alkylator destabilizing local DNA duplex structure
37. 5-Fluorouracil and its active metabolite FdUMP cause DNA damage in human SW620 colon adenocarcinoma cell line
38. Influence of irofulven, a transcription-coupled repair-specific antitumor agent, on RNA polymerase activity, stability and dynamics in living mammalian cells
39. What histone code for DNA repair?
40. Mitosis-specific MPM-2 phosphorylation of DNA topoisomerase IIα is regulated directly by protein phosphatase 2A
41. Down-Regulation of DNA Topoisomerase IIα Leads to Prolonged Cell Cycle Transit in G2and Early M Phases and Increased Survival to Microtubule-Interacting Agents
42. Molecular cross-talk between the transcription, translation, and nonsense-mediated decay machineries
43. Recruitment of cdc2 kinase by DNA topoisomerase II is coupled to chromatin remodeling
44. Mitotic Phosphorylation of DNA Topoisomerase II α by Protein Kinase CK2 Creates the MPM-2 Phosphoepitope on Ser-1469
45. Resistance mechanisms associated with altered intracellular distribution of anticancer agents
46. The catalytic activities of DNA topoisomerase II are most closely associated with the DNA cleavage/religation steps
47. Expression Pattern of Purinergic Signaling Components in Colorectal Cancer Cells and Differential Cellular Outcomes Induced by Extracellular ATP and Adenosine.
48. Down-Regulation of DNA Topoisomerase IIα Leads to Prolonged Cell Cycle Transit in G2 and Early M Phases and Increased Survival to Microtubule-Interacting Agents
49. Genotype- or Phenotype-Targeting Anticancer Therapies? Lessons from Tumor Evolutionary Biology.
50. From DNA damage to G2 arrest: the many roles of topoisomerase II.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.